SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 47.41

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.33M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-30 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

N/A

USD 126.52B
REGN Regeneron Pharmaceuticals Inc

N/A

USD 69.68B
ARGX argenx NV ADR

N/A

USD 37.97B
ALNY Alnylam Pharmaceuticals Inc

N/A

USD 31.94B
ONC BeiGene, Ltd.

N/A

USD 28.70B
RPRX Royalty Pharma Plc

N/A

USD 19.31B
SMMT Summit Therapeutics PLC

N/A

USD 14.57B
UTHR United Therapeutics Corporatio..

N/A

USD 14.37B
INCY Incyte Corporation

N/A

USD 14.22B
MRNA Moderna Inc

N/A

USD 13.74B

ETFs Containing SWTX

SAFE:CA Global X Equal Weight Can.. 27.09 % 0.00 %

N/A

CAD 2.65M
HFIN:CA Hamilton Enhanced Canadia.. 9.82 % 0.00 %

N/A

CAD 0.20B
HFN:CA Hamilton Canadian Financi.. 8.87 % 0.00 %

N/A

CAD 0.01B
HLIF:CA Harvest Canadian Equity I.. 3.35 % 0.00 %

N/A

CAD 0.12B
CNCR Loncar Cancer Immunothera.. 2.69 % 0.79 %

N/A

USD 8.35M
CDEF:CA Manulife Smart Defensive .. 2.51 % 0.00 %

N/A

CAD 1.43M
BBP Virtus LifeSci Biotech Pr.. 2.16 % 0.79 %

N/A

USD 0.02B
CEW:CA iShares Equal Weight Banc.. 0.00 % 0.60 %

N/A

CAD 0.24B
DXM:CA 0.00 % 0.67 %

N/A

N/A
FIE:CA iShares Canadian Financia.. 0.00 % 0.97 %

N/A

CAD 1.08B
HEF:CA 0.00 % 0.83 %

N/A

N/A
HPR:CA Global X Active Preferred.. 0.00 % 0.63 %

N/A

CAD 0.99B
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

N/A

CAD 0.08B
IDNA iShares Genomics Immunolo.. 0.00 % 0.00 %

N/A

USD 0.12B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

N/A

N/A
XMD:CA iShares S&P/TSX Completio.. 0.00 % 0.61 %

N/A

CAD 0.27B
BANK:CA Evolve Canadian Banks and.. 0.00 % 0.39 %

N/A

CAD 0.38B
BNC:CA Purpose Canadian Financia.. 0.00 % 0.68 %

N/A

N/A
TQCD:CA TD Q Canadian Dividend ET.. 0.00 % 0.00 %

N/A

CAD 0.38B
TPIF Timothy Plan Internationa.. 0.00 % 0.00 %

N/A

USD 0.12B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 31.22% 91% A- 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.22% 91% A- 94% A
Trailing 12 Months  
Capital Gain -3.68% 77% C+ 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.68% 77% C+ 50% F
Trailing 5 Years  
Capital Gain 75.59% 83% B 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 75.59% 83% B 63% D
Average Annual (5 Year Horizon)  
Capital Gain 8.55% 60% D- 61% D-
Dividend Return 8.55% 60% D- 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 55.68% 58% F 34% F
Risk Adjusted Return 15.36% 69% C- 49% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector